En
En
Fr
Fr
De
De
It
It
Es
Es
Cn
Cn
16 YEARS OF INTERNATIONAL CLINICAL EXPERIENCE IN TRANSPLANTATION OF HUMAN EMBRYONIC/FETAL STEM CELLS
THE WORLD'S LARGEST CLINICAL EXPERIENCE IN EMBRYONIC STEM CELL TRANSPLANTATION FOR VARIOUS DISEASES AND CONDITIONS

Home
About EmCell
EmCell Therapy
Our Experience
List of Diseases:
Oncology
Diabetes Mellitus
Nervous System
Anti-Aging
Age-Related Problems
Immune Deficiency
Endoscopic Treatment of Liver Diseases
Congresses and Conferences
Video and other materials
FAQs
Mail Center

Laboratory tests of patient R.



List of diseases > Nervous system > Duchenne Muscular Dystrophy > Case reports > Laboratory tests

Average blood count

Parameters   11.22.99 05.16.00 11.13.00
Erythrocytes, x1012/l   4.0 3.7 3.8
Erythrocytes with HbF, %   not detected not detected not detected
Hb, g/l   130 126 126
Color index   0.98 1.0 0.9
Thrombocytes, x109/l       220
Leukocytes, x109/l   4.0 4.6 7.6
Basophils, %        
Eosinophils, %   1 1 3
Stebcells, %   2 7 1
Segmentnuclars, %   56 72 54
Lymphocytes, %   37 17 46
Monocytes, %   4 3 4
ESR, mm/hr   4 3 6

Chemistry

Parameters   11/22/99 05/16/00 11/13/00
Bilirubin total, mmol/l   16 17.1 17.4
Bilirubin direct, mmol/l   Neg. Neg. Neg.
Bilirubin indirect, mmol/l   16 17.1 17.4
ALT, mmol/l   0.38 0.36 0.37
ACT, mmol/l   0.21 0.21  
Thymol test, units   2.4 3.4 2.6
Protein total, g/l     68 74
Albumin, %     56.5 47
Globulin, % 43.5 53
-alpha 1, % 5.1 5
-alpha 2, % 2.98 15
-beta, % 12.8 13
-gamma, % 15.8 19.5
Protein index 1.3 0.89
Seromucoid, g/l     0.195 0.165
CRP     Neg. Neg.
Beta-lipoproteids, units       44
Creatinine, mmol/l   0.071 0.066 0.068
Urea, mmol/l   6.8 6.3 6.6
Blood sugar, mmol/l        

 

Immunological Test

Parameter Norm MCAB 06.15.99 11.22.99 05.16.00 11.13.00
% x109/l % x109/l % x109/l % x109/l % x109/l
B-lymphocytes /CD19+/ 8.84+1.44 0.21+0.08 15.27 0.367 10.17 0.151 14.05 0.11 8.06 0.28
T-lymphocytes /CD3+/ 60.94+1.49 1.34+0.02 23.15 0.556 41.22 0.611 46.62 0.33 59.14 2.07
T-helpers /CD4+/ 38.55+0.84 0.86+0.01 13.42 0.322 25.27 0.374 30.73 0.24 36.02 1.26
T-suppressors /CD8+/ 23.89+2.01 0.52+0.01 11.75 0.282 13.03 0.193 11.15 0.087 19 0.66
NK – natural killers /CD16+/ 18.96+4.43 0.39+0.01 13.95 0.335 5.06 0.075 4.69 0.037 12.09 0.42
Helper-Supressor Ratio (CD4+/CD8+) 1.63+0.04   1.14   1.93   2.75   1.89  
Leukocytes       4.8   4   4.6   7.6
Lymphocytes     50   37   7   46  
Absolute Lymphocytes       2.4   1.48   0.78   3.49



























News
2008-09-25
Prof. Alexander I. Smikodub attended European Congress on Anti-Aging and

Prof. Alexander I. Smikodub attended European Congress on Anti-Aging and Aesthetic Medicine held in Dusseldorf, Germany on September 11-14, 2008 as ...
  Other news
 
Publications

25. Application Of Embryonic Cell Suspensions In Patients With Solid Tumors Before Initiation Of Radical Treatment

Smikodub O.
Cell Therapy Clinic of National Medical University and Embryonic Tissues Center EmCell
Patients with solid tumors and complications that made initiations of anti-cancer treatment impossible, were ...
  Other publications
 
Patents

Medicinal preparation based on fetal cell suspension having immune substituting effect for patients with acquired immune ...
   
 
Copyright © 1999-2009 EmCell.com